We obtained a list of genes that are commonly up or downregulated upon treatment of the ER+ breast cancer cell line, MCF-7 with SOC (Fig. 1a), which we named the ‘SOC sensitivity’ signature (Supplementary Data 1). Here, UBXN11 is linked to breast carcinoma.